Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration
Fc receptor-like A is positively correlated with poor outcomes in RCC patients and plays an oncogenic role in RCC through the pERK1/2-MMP2 pathway. Patients with RCC might benefit from immunotherapy targeting FCRLA.
Authors
- Hao Lin (ORCID: https://orcid.org/0000-0002-1005-4585)
- Jinwen Liu (ORCID: https://orcid.org/0000-0003-2823-0396)
- Z H Zhang
- Junpeng Liu (ORCID: https://orcid.org/0000-0001-9222-3663)
- Bin Huang (ORCID: https://orcid.org/0000-0002-6668-4885)
- Yu‐zhao Lin
- Chong‐jiang Tian
- Yun‐zhi Yang
- Yi‐fan Jiang
- Yi‐liang Fang
Institutions
- Sun Yat-sen University (CN)
- Shantou University (CN)
- Second Affiliated Hospital of Shantou University Medical College (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70072
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Natural Science Foundation of China